Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus — an antibacterial drug in heart protection-Reference-Cited by-同舟云学术

Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus — an antibacterial drug in heart protection

Published:2022-02-03 Issue:4 Volume:395 Page:429-444
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Sobot Nikola M.,Sobot Tanja S.,Jeremic Jovana N.,Bolevich Sergey B.,Bolevich Stefani S.,Mitrovic Slobodanka Lj.,Fisenko Vladimir P.,Inic Sofija G.,Samanovic Andjela D. Milojevic,Rankovic Marina R.,Srejovic Ivan M.,Zivkovic Vladimir I.,Jakovljevic Vladimir Lj.

Funder

Faculty of Medical Sciences University of Kragujevac

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-021-02179-y.pdf

Reference44 articles.

1. Bhatt LK, Veeranjaneyulu A (2012) A therapeutic approach to treat cardiovascular dysfunction of diabetes. Exp Toxicol Pathol 64:847–853. https://doi.org/10.1016/j.etp.2011.03.005

2. Bhatt LK, Veeranjaneyulu A (2014) Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes. Arch Med Res 45:203–209. https://doi.org/10.1016/j.arcmed.2014.01.008

3. Bilu C, Einat H, Barak O, Zimmet P, Vishnevskia-Dai V, Govrin A, Agam G, Kronfeld-Schor N (2019) Linking type 2 diabetes mellitus, cardiac hypertrophy and depression in a diurnal animal model. Sci Rep 9(1):11865. https://doi.org/10.1038/s41598-019-48326-7